Eculizumab
CAS 219685-50-4Biologic
Overview
Eculizumab is a monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome by inhibiting the complement component C5. It prevents the destruction of blood cells and can improve kidney function and reduce symptoms of these diseases.
Therapeutic areas
HematologyNephrologyNeurology
Verified Supplier Partner
Do you supply Eculizumab? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.